Exclusive Interviews

In part 6 of this Exclusive Interview, Dr. Mark Molitch explains the diabetes treatment objective in patients who have undergone a transplant in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 7, the conclusion of this Exclusive Interview, Dr. Mark Molitch talks with with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the importance of good blood glucose control and continued control in post-transplant patients as referenced in his ADA presentation.

In part 1 of this Exclusive Interview, Dr. Osama Hamdy talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the cultural issues that impact diabetes treatment and the importance of factoring in cultural differences.

In the conclusion of this Exclusive Interview, Drs. Sood and Messer talk with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about their individual diet philosophies and behavior modification.

Dr. Todd Hobbs is Vice President and Chief Medical Officer for Novo Nordisk in North America, where he leads the organization’s focus on the implications of diabetes for the patient, healthcare system, and healthcare professionals. He provides overall medical guidance to Novo Nordisk’s diabetes and obesity-related projects. Prior to working at Novo Nordisk, Dr. Hobbs had established a clinical practice based in Louisville, Kentucky, focusing on the intensive management of patients with diabetes of all ages, and served as chairman of the medicine department for a large regional medical center in Kentucky. During this 10year clinical career, he cared for more than 2,500 adults and children with diabetes, including outpatient and inpatient care, as well as intensive care.

Dr. Todd Hobbs discusses diabetes and obesity related projects at Novo Nordisk, including the results of the DEVOTE trial: the cardiovascular outcomes trial for degludec, basal insulin.

n this Exclusive Interview, Dr. Todd Hobbs talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about data from various important trials as well as the importance of their unique product degludec.

In part 1 of this Exclusive Interview, Dr. Todd Hobbs talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about his work at Novo Nordisk not only as chief medical officer but also as a person with type 1.

In part 2 of this Exclusive Interview, Dr. Todd Hobbs talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about DEVOTE data and how degludec works.

In part 3 of this Exclusive Interview, Dr. Todd Hobbs explains the DUAL-7 data in a converstion with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.